Market

BMO Capital raises Regeneron stock price target to $725 on Dupixent strength

BMO Capital raises Regeneron stock price target to $725 on Dupixent strength
Read More

Related Posts

DeNinno, Wabtec exec VP, sells $1.07 million in WAB stock

DeNinno, Wabtec exec VP, sells $1.07 million in WAB stock

German industrial orders rise more than expected in October

German industrial orders rise more than expected in Oct...

This Tesla move could help the EV maker shake a sales slump

This Tesla move could help the EV maker shake a sales s...

Inflation didn’t get any worse before the government shutdown. The Fed is expected to cut rates again.

Inflation didn’t get any worse before the government sh...

Our Roth conversion triggered extra fees for Medicare premiums. Can I appeal?

Our Roth conversion triggered extra fees for Medicare p...

Here’s the No. 1 way to protect your investment portfolio from market bubbles and FOMO

Here’s the No. 1 way to protect your investment portfol...